📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Impact of Type II LRRK2 inhibitors on signaling and mitophagy. (2021)

First Author: Tasegian A

Attributed to: Mitophagy Signalling in Health and Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1042/bcj20210375

PubMed Identifier: 34515301

Publication URI: http://europepmc.org/abstract/MED/34515301

Type: Journal Article/Review

Volume: 478

Parent Publication: The Biochemical journal

Issue: 19

ISSN: 0264-6021